Top Navigation
Global
Choose your region
Don't see your region/country listed? Visit our global website
Related content
Chief Human Resources Officer Stephanie Franklin discusses our unique culture at Vertex and how we bring our culture to life.
Our CEO and President, Reshma Kewalramani shares her thoughts on how Vertex is rethinking work and education in an extremely competitive talent market
Vertex’s 14th annual Global Day of Service was our most impactful to date, with 57% employee participation across 20 countries and more than 6,000 hours of service contributed to our communities.
In this section
Our scientists don’t see the impossible as an obstacle; they see it as a good place to start
See where our scientific discoveries happen
Volunteers who participate in clinical trials help make new medicines a reality
Information about our Early Access program and how we evaluate requests
Instructions on how to submit a report
We work with the kidney disease community to ensure their voices are represented in all that we do
See how we're engaging with the sickle cell disease community
Discover how we're inspiring and equipping the next generation to love science and pursue a career in STEM
Explore our commitment to limiting our environmental impacts and operating our business in a sustainable manner
Read more about how we operate our business responsibly, and how in 2022 we created more ways to positively impact patients, employees, our communities and the environment
Our commitment to inclusion, diversity and equity (ID&E) is longstanding and achieving our ambition takes collective action and shared ownership. Learn more about our approach from Vice President of Talent and ID&E Diana Cruz Solash.
Read about three exceptional Vertex employees who have been recognized for their accomplishments by three leading organizations.
Discover more about our relentless efforts to improve the lives of patients, employees and our communities.
The Vertex Foundation aims to help support the entire family — including educational funding for people living with cystic fibrosis, their loved ones and caregivers.
Listen to James Sinclair, Senior Director of Engineering & Applied Physics, talk about how our engineers partner with our scientists to optimize the drug discovery process.
Learn about how mRNA therapy could potentially benefit people living with serious diseases.
Paul Negulescu, Senior Vice President, Research, talks about the journey his team has taken over the last 20 years.
Listen to Fred Van Goor, Vice President of Cystic Fibrosis Research, talk about our commitment to pursuing new therapeutic advances for all people living with cystic fibrosis and how this commitment drives scientific innovation.
Rebecca Hunt, Vice President of Patient and Community Engagement, highlights Vertex’s uncompromising commitment to patients.
We are relentless in our quest to improve the lives of people living with serious diseases. Thanks to the dedication of teams led by Paul Negulescu, Fred Van Goor and Sabine Hadida, our medicines have profoundly impacted the cystic fibrosis community.
Learn more about cystic fibrosis and how we are committed now more than ever to discovering new therapeutic advances for all people living with the disease.
Mark Higgins, Senior Director of Clinical Development, highlights Vertex’s patient-first approach to clinical trials and discusses his experience discovering potential treatments for people with cystic fibrosis.
The Vertex Foundation Scholarship helps eligible people with cystic fibrosis and their families in the U.S. and Canada pursue higher education degrees. Recipients will be awarded $5,000 USD/CAD toward the 2023-2024 academic year.
Cystic fibrosis is a rare, genetic, progressive disease, in which symptoms and organ damage can manifest very early in life. These may not, however, be outwardly visible in all children and while some children can appear well on the outside, what is happening inside their bodies can tell a different story.